MBL2 and ovarian carcinoma: The median serum MBL in the OC patients (714 ng/ml) did not differ significantly from that of the control group (641 ng/ml) (full details are presented in Supplementary Table 2) However, MBL2 A/A homozygotes suffering from ovarian cancer had generally higher MBL concentrations (median 1,692 ng/ml) than their counterparts in the C (1,231 ng/ml), NO (1,054 ng/ml) or BT (1,301 ng/ml) groups (Fig. 2a).